DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
« Back to Dashboard
Epinephrine; lidocaine hydrochlorideis the generic ingredient in nine branded drugs marketed by Carlisle, Belmora Llc, Eastman Kodak, Hospira, West-ward Pharms Int, Abbott, Bel Mar, Dell Labs, Intl Medication, Watson Labs, Pharmaton, Septodont, Dentsply Pharm, Astrazeneca, Fresenius Kabi Usa, Vyteris, Iomed, and Empi, and is included in thirty-one NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.
Epinephrine; lidocaine hydrochloride has eight patent family members in seven countries.
There are twenty-one drug master file entries for epinephrine; lidocaine hydrochloride. Ten suppliers are listed for this compound.
Recent Clinical Trials for epinephrine; lidocaine hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
|University of Chile||Phase 4|
|Loma Linda University||Phase 4|
|Bozyaka Training and Research Hospital||Phase 4|